Your browser doesn't support javascript.
loading
Phase I open-label study of afatinib plus vinorelbine in patients with solid tumours overexpressing EGFR and/or HER2.
Bahleda, Rastislav; Varga, Andrea; Bergé, Yann; Soria, Jean-Charles; Schnell, David; Tschoepe, Inga; Uttenreuther-Fischer, Martina; Delord, Jean-Pierre.
Afiliação
  • Bahleda R; Département d'Innovation Thérapeutique et d'Essais Précoces, Institut Gustave Roussy, 114 Rue Edouard Vaillaint, Villejuif 94805, France.
  • Varga A; Département d'Innovation Thérapeutique et d'Essais Précoces, Institut Gustave Roussy, 114 Rue Edouard Vaillaint, Villejuif 94805, France.
  • Bergé Y; Department of Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer-Oncopole, Toulouse 31100, France.
  • Soria JC; Département d'Innovation Thérapeutique et d'Essais Précoces, Institut Gustave Roussy, 114 Rue Edouard Vaillaint, Villejuif 94805, France.
  • Schnell D; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, Biberach 88397, Germany.
  • Tschoepe I; Boehringer Ingelheim France S.A.S., Reims 51100, France.
  • Uttenreuther-Fischer M; TA Oncology, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, Biberach 88397, Germany.
  • Delord JP; Department of Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer-Oncopole, Toulouse 31100, France.
Br J Cancer ; 118(3): 344-352, 2018 02 06.
Article em En | MEDLINE | ID: mdl-29337963
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article